In the realm of systems biology, illuminating the darker corners of cellular processes is a formidable challenge. Yet, Harvard University’s Xiaokang Lun is pushing the boundaries of what’s possible by harnessing the power of DNA in an innovative way. His breakthrough method, amplification by cyclic extension (ACE), holds the potential to revolutionize the field of mass cytometry, and by extension, our understanding of complex biological systems and disease mechanisms.
Mass cytometry is an indispensable tool for probing the intricate network of proteins that orchestrate cellular activities. However, its ability to detect low-abundance proteins – those that are present in small quantities but with potentially significant roles – has been a significant limitation. Lun’s pioneering ACE method addresses this shortcoming, enhancing the detection of these elusive proteins by a remarkable 500-fold.
The ACE technique is a game-changer. It employs DNA molecules as signal amplifiers, in conjunction with metal-tagged antibodies. Traditional mass cytometry involves the metal tag binding directly to the antibody, which then binds to the target protein. The ACE method, however, introduces short DNA polymers to the antibody, which extend over a series of amplification steps. A metal-conjugated detector polymer is bound to an oligonucleotide strand that recognizes these extender sequences, tagging the amplified DNA polymers. This ingenious use of DNA as a signal booster overcomes the signal-to-background problem of low-abundance targets, enabling the detection of proteins and post-translational modification (PTM) sites that were previously difficult to study.
The potential applications of ACE are far-reaching. By enhancing the sensitivity of mass cytometry, it allows researchers to delve deeper into cellular processes, providing a more comprehensive understanding that could catalyze advancements in precision medicine and drug development. The ability to detect low-abundance proteins more effectively could also unearth novel biomarkers for diseases and potentially uncover new therapeutic targets.
Moreover, ACE paves the way for studying smaller cells that traditional methods couldn’t detect, broadening the potential applications of mass cytometry. It also enhances the capabilities of imaging mass cytometry (IMC), overcoming the limited antibody signal issue that plagues traditional IMC, while still offering the benefits of mass cytometry that avoid autofluorescence in standard fluorescence microscopy.
In essence, Lun’s inventive approach presents an exciting new frontier for cytometry research, one that is set to enrich our understanding of biological systems and disease mechanisms. It illustrates the transformative power of innovative methodologies in biotechnology, and the profound impact they can have on our exploration of the microscopic world within us. As we continue to unravel the complexities of cellular processes, tools like ACE will be instrumental in driving these discoveries forward.
Read more from the-scientist.com
